Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Halo Collective Inc. AKAN Akanda Corp. 13D/A — 2y
Michael J. Levitt CORZ Core Scientific, Inc. 13D/A 9.33% 2y
Matt Minnis CORZ Core Scientific, Inc. 13D/A 8.45% 2y
Roger James Hamilton GNS Genius Group Ltd 13G 8.53% 2y
ROSE STUART A REX REX AMERICAN RESOURCES Corp 13G/A 9.2% 2y
MBC Ventures Limited ANGH Anghami Inc 13G/A 13.7% 2y
IDG-Accel China Growth Fund III L.P. JG Aurora Mobile Ltd 13G/A 7.4% 2y
Vanessa Tavares Esteves AFYA Afya Ltd 13G/A 5.5% 2y
Renato Tavares Esteves AFYA Afya Ltd 13G/A 5.7% 2y
Rosalind Advisors, Inc. GTHP Guided Therapeutics Inc 13G/A 0% 2y
Lílian Tavares Esteves de Carvalho AFYA Afya Ltd 13G/A 5.7% 2y
Rosalind Advisors, Inc. SIEN Sientra, Inc. 13G/A 0% 2y
Balderton Capital VI, S.L.P. SOPH SOPHiA GENETICS SA 13G/A 5.1% 2y
Nicolau Carvalho Esteves AFYA Afya Ltd 13G/A 27.6% 2y
Raymond T. Hyer INTZ Intrusion Inc 13G/A 11.5% 2y
OMP AY Preferred Limited KNOP KNOT Offshore Partners LP 13G/A 6.9% 2y
Yehuda Kahane ITRN Ituran Location & Control Ltd. 13G/A 7.06% 2y
Birchview Capital, LP ELUT Elutia Inc. 13G/A 8.76% 2y
Walleye Capital LLC AGNG Global X Funds 13G/A 0% 2y
Izzy Sheratzky ITRN Ituran Location & Control Ltd. 13G/A 19.85% 2y
Yocto Investments LLC QETA Quetta Acquisition Corp 13G 22.02% 2y
NDX B.V. EGOX Next.e.GO N.V. Ordinary Shares 13G 45.5% 2y
LIAN JIA ENTERPRISES LIMITED CCG Cheche Group Inc. 13G 6.2% 2y
Halo Collective Inc. AKAN Akanda Corp. 13D 13% 2y
Halo Collective Inc. AKAN Akanda Corp. 13G/A 0% 2y
Sofinnova Venture Partners IX, L.P. ("SVP IX") GRTXD Galera Therapeutics, Inc. 13D/A 0% 2y
Fairmount Funds Management LLC COGT Cogent Biosciences, Inc. 13D/A 18.89% 2y
Deerfield Management Company, L.P. LRMR Larimar Therapeutics, Inc. 13D/A 34.82% 2y
TELUS CORP TIXT TELUS International (Cda) Inc. Subordinate Voting Shares 13D/A 59.3% 2y
Yi ZHANG LSBWF LakeShore Biopharma Co., Ltd. 13G/A 42.6% 2y
Engaged Capital LLC PRAA Pra Group Inc 13D/A 4.97% 2y
Coliseum Capital Management, LLC UTI Universal Technical Institute Inc 13D/A 17.4% 2y
GENERAL ATLANTIC, L.P. HRT HireRight Holdings Corporation 13D/A 47.7% 2y
Compagnie Maritime Belge NV CMBT Cmb.Tech NV 13D/A 53.37% 2y
R. Scott Asen DRRX Durect Corp 13G 5.13% 2y
HERALD INVESTMENT MANAGEMENT Ltd IDN Intellicheck, Inc. 13G 5.03% 2y
TANG CAPITAL MANAGEMENT, LLC THRX Theseus Pharmaceuticals, Inc. Common Stock 13D/A 100% 2y
Cano Health, Inc. MSPR MSP Recovery, Inc. 13D/A 33.5% 2y
MAK CAPITAL ONE LLC AGYS Agilysys Inc 13D/A 8.8% 2y
Berkshire Hathaway Inc DVA Davita Inc. 13D/A 41.2% 2y
5AM Ventures VI, L.P. ELVN Enliven Therapeutics, Inc. 13D/A 9.3% 2y
Kenneth Orr CRGE Charge Enterprises, Inc. Common Stock 13D 9.5% 2y
Tontine Capital Partners, L.P. IESC IES Holdings, Inc. 13D/A 56.5% 2y
Robby Sai Kit Chang ABTC American Bitcoin Corp. 13D 8.5% 2y
Funicular Funds, LP ATCH AtlasClear Holdings, Inc. 13G 9.99% 2y
MILLENNIUM MANAGEMENT LLC KALA KALA BIO, Inc. 13G 5% 2y
Mithaq Capital SPC PLCE Childrens Place, Inc. 13D 56.1% 2y
RJL 18 Capital Canada LP ABTC American Bitcoin Corp. 13G 8.3% 2y
Roxy Capital Corp ABTC American Bitcoin Corp. 13G 8.5% 2y
CVI Investments, Inc. TENX Tenax Therapeutics, Inc. 13G 9.9% 2y